Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gajanan N. Sapkal
Observed names:
G N Sapkal,
G. N. SAPKAL,
G. N. Sapkal,
G. Sapkal,
G.N. Sapkal,
Gajanan N Sapkal,
Gajanan Sapkal,
Sapkal Gajanan
show all 8
Institutions:
ICMR-National Institute of Virology,
Academy of Scientific and Innovative Research
Observed institutions:
B. J. Medical College & Sassoon Hospital,
Baba Raghav Das Medical College,
Indian Council of Medical Research,
Suamandeep Vidyapeeth University,
ICMR-National Institute of Virology,
Academy of Scientific and Innovative Research
show all 6
ORCID:
0000-0001-9283-8860
Observed ORCID:
0000-0001-9283-8860
OpenAlex ID:
A5010095366
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
2021
·
Raches Ella
, Krishna Mohan Vadrevu
, et al.
·
The Lancet Infectious Diseases
·
422
PDF
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
2021
·
Raches Ella
, Siddharth Reddy
, et al.
·
The Lancet Infectious Diseases
·
378
PDF
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
2021
·
Raches Ella
, Siddarth Reddy
, et al.
·
The Lancet
·
344
PDF
Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
2021
·
Pragya D Yadav
, Gajanan N Sapkal
, et al.
·
Clinical Infectious Diseases
·
251
PDF
Prevalence of SARS-CoV-2 infection in India
2020
·
Manoj V. Murhekar
, Tarun Bhatnagar
, et al.
·
The Indian Journal of Medical Research
·
202
PDF
Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey
2019
·
Manoj V Murhekar
, P Kamaraj
, et al.
·
The Lancet Global Health
·
150
PDF
Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2
2021
·
Gajanan N Sapkal
, Pragya D Yadav
, et al.
·
Journal of Travel Medicine
·
121
PDF
Enteroviruses in Patients with Acute Encephalitis, Uttar Pradesh, India
2009
·
Gajanan N. Sapkal
, Vijay P. Bondre
, et al.
·
Emerging infectious diseases
·
118
PDF
First isolation of SARS-CoV-2 from clinical samples in India
2020
·
Prasad Sarkale
, Savita Patil
, et al.
·
The Indian Journal of Medical Research
·
112
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin
2021
·
Pragya D Yadav
, Gajanan N Sapkal
, et al.
·
Journal of Travel Medicine
·
109
PDF
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
2021
·
Pragya D. Yadav
, Raches Ella
, et al.
·
Nature Communications
·
107
PDF
Introduction of Japanese Encephalitis Virus Genotype I, India
2011
·
Pradip V. Fulmali
, Gajanan N. Sapkal
, et al.
·
Emerging infectious diseases
·
96
PDF
Japanese Encephalitis: A Brief Review on Indian Perspectives
2018
·
Reshma Kulkarni
, Gajanan N. Sapkal
, et al.
·
The Open Virology Journal
·
93
PDF
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation
2021
·
Brunda Ganneru
, Harsh Jogdand
, et al.
·
iScience
·
91
Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial
2021
·
Raches Ella
, Siddarth Reddy
, et al.
·
medRxiv
·
77
PDF
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
2021
·
Sreelekshmy Mohandas
, Pragya D. Yadav
, et al.
·
iScience
·
74
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
2020
·
Gajanan Sapkal
, Anita Shete-Aich
, et al.
·
The Indian Journal of Medical Research
·
73
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
2020
·
Gururaj Rao Deshpande
, Gajanan N. Sapkal
, et al.
·
The Indian Journal of Medical Research
·
70
Zika virus outbreak in Rajasthan, India in 2018 was caused by a virus endemic to Asia
2019
·
Pragya D. Yadav
, Bharati Malhotra
, et al.
·
Infection Genetics and Evolution
·
67
Genetic characterization of Bagaza virus (BAGV) isolated in India and evidence of anti-BAGV antibodies in sera collected from encephalitis patients
2009
·
Vijay P. Bondre
, Gajanan N. Sapkal
, et al.
·
Journal of General Virology
·
64
Detection and Isolation of Japanese Encephalitis Virus From Blood Clots Collected During the Acute Phase of Infection
2007
·
Gajanan N. Sapkal
, Nitin S. Wairagkar
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
60
Horizontal and vertical transmission of dengue virus type 2 in highly and lowly susceptible strains of Aedes aegypti mosquitoes.
2001
·
D T Mourya
, Gokhale
, et al.
·
PubMed
·
56
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
2021
·
Mohandas Sreelekshmy
, Yadav Pragya Dhruv
, et al.
·
Viruses
·
55
PDF
Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum
2021
·
Gajanan N. Sapkal
, Pragya D. Yadav
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
55
PDF
Neutralization Potential of Covishield Vaccinated Individuals Sera Against B.1.617.1
2021
·
Pragya D Yadav
, Gajanan N Sapkal
, et al.
·
Clinical Infectious Diseases
·
51
PDF
Show more works
View as search
Works count:
158
Citation count:
5,246
H-index:
39
I10-index:
93
Year
Topic
Type
